ViCentra, a Netherlands-based medical device firm, has successfully secured an extra $13 million in Series D funding, solidifying a promising…
Read More
Dutch MedTech startup ViCentra raises €72.4 million to scale their Kaleido insulin patch pump
ViCentra, an Utrecht-based medical device company innovating insulin delivery for people with diabetes, announced the successful close of a €72.4…
Read More
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)
Company plans to meet with FDA regarding potential sNDA submission in 1H 2025 Call planned today at 8:30 a.m. (ET)…
Read More
